Log in to save to my catalogue

Effective gene therapy for haemophilic mice with pathogenic factor IX antibodies

Effective gene therapy for haemophilic mice with pathogenic factor IX antibodies

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_82a93c90680c4bf4959b0407338446dc

Effective gene therapy for haemophilic mice with pathogenic factor IX antibodies

About this item

Full title

Effective gene therapy for haemophilic mice with pathogenic factor IX antibodies

Publisher

London: Nature Publishing Group UK

Journal title

EMBO molecular medicine, 2013-11, Vol.5 (11), p.1698-1709

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

Formation of pathogenic antibodies is a major problem in replacement therapies for inherited protein deficiencies. For example, antibodies to coagulation factors (‘inhibitors’) seriously complicate treatment of haemophilia. While immune tolerance induction (ITI) protocols have been developed, inhibitors against factor IX (FIX) are difficult to erad...

Alternative Titles

Full title

Effective gene therapy for haemophilic mice with pathogenic factor IX antibodies

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_82a93c90680c4bf4959b0407338446dc

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_82a93c90680c4bf4959b0407338446dc

Other Identifiers

ISSN

1757-4676

E-ISSN

1757-4684

DOI

10.1002/emmm.201302859

How to access this item